{
  "spec_version": "3",
  "endpoint": "timeline",
  "stock_code": "4544",
  "company_name": "H.U.グループホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4544/",
  "api_url": "/api/4544/timeline.json",
  "updated": "2026-09-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4544/",
  "source": {
    "primary": [
      "有価証券報告書"
    ],
    "extraction": "有価証券報告書の沿革を基礎に、社史・報道で補完",
    "row_field": "source"
  },
  "timeline": [
    {
      "date": "1950/12",
      "importance": 2,
      "event": "富士臓器製薬を設立",
      "source": "有価証券報告書"
    },
    {
      "date": "1966/12",
      "importance": 2,
      "event": "診断用薬事業に参入",
      "source": "有価証券報告書"
    },
    {
      "date": "1970/6",
      "importance": 2,
      "event": "臨床検査センター東京スペシアル レファレンス ラボラトリーを設立",
      "source": "有価証券報告書"
    },
    {
      "date": "1970/8",
      "importance": 1,
      "event": "診断用薬の海外販売を開始",
      "source": "有価証券報告書"
    },
    {
      "date": "1983/4",
      "importance": 2,
      "event": "富士レビオに商号変更",
      "source": "有価証券報告書"
    },
    {
      "date": "1983/9",
      "importance": 1,
      "event": "東京証券取引所市場第二部に上場",
      "source": "有価証券報告書"
    },
    {
      "date": "1987/6",
      "importance": 1,
      "event": "東京証券取引所市場第一部に指定替え",
      "source": "有価証券報告書"
    },
    {
      "date": "1990/8",
      "importance": 1,
      "event": "エスアールエルが東京証券取引所市場第二部に上場",
      "source": "有価証券報告書"
    },
    {
      "date": "1998/11",
      "importance": 2,
      "event": "Centocor Diagnostics Pennsylvaniaを子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2000/4",
      "importance": 1,
      "event": "エスアールエルが日本ステリを完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2000/6",
      "importance": 2,
      "event": "医薬事業をユーシービージャパンに譲渡",
      "source": "有価証券報告書"
    },
    {
      "date": "2004/11",
      "importance": 3,
      "event": "エスアールエルを子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/3",
      "importance": 1,
      "event": "エスアールエルが東京証券取引所市場第一部での上場を廃止",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/4",
      "importance": 2,
      "event": "エスアールエルを完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/6",
      "importance": 1,
      "event": "委員会等設置会社に移行",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/7",
      "importance": 3,
      "event": "持株会社に移行",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/7",
      "importance": 2,
      "event": "みらかホールディングスに商号変更",
      "source": "有価証券報告書"
    },
    {
      "date": "2006/5",
      "importance": 1,
      "event": "CanAg Diagnostics ABを子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2009/10",
      "importance": 1,
      "event": "エスアールエルがケアレックスを完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2010/4",
      "importance": 1,
      "event": "エスアールエルが日本医学臨床検査研究所を完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2010/9",
      "importance": 2,
      "event": "富士レビオがInnogenetics N.V.を完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2011/11",
      "importance": 3,
      "event": "Caris Diagnostics, Inc.を完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2012/10",
      "importance": 1,
      "event": "本社を移転",
      "source": "有価証券報告書"
    },
    {
      "date": "2015/2",
      "importance": 2,
      "event": "Baylor Miraca Genetics Laboratories, LLCの持分を取得",
      "source": "有価証券報告書"
    },
    {
      "date": "2017/7",
      "importance": 1,
      "event": "みらか中央研究所を設立",
      "source": "有価証券報告書"
    },
    {
      "date": "2017/11",
      "importance": 3,
      "event": "CDx Holdings, Inc.の全株式を売却し連結対象から除外",
      "source": "有価証券報告書"
    },
    {
      "date": "2019/2",
      "importance": 1,
      "event": "セルメスタを完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/7",
      "importance": 2,
      "event": "H.U.グループホールディングスに商号変更",
      "source": "有価証券報告書"
    },
    {
      "date": "2022/4",
      "importance": 1,
      "event": "プライム市場に移行",
      "source": "有価証券報告書"
    },
    {
      "date": "2022/7",
      "importance": 1,
      "event": "富士レビオ・ホールディングスがFluxus, Inc.を完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2023/1",
      "importance": 1,
      "event": "エスアールエルが東京セントラルパソロジーラボラトリーを完全子会社化",
      "source": "有価証券報告書"
    },
    {
      "date": "2023/7",
      "importance": 1,
      "event": "本社を移転",
      "source": "有価証券報告書"
    },
    {
      "date": "2024/12",
      "importance": 1,
      "event": "ガイアメディケアを子会社化",
      "source": "有価証券報告書"
    }
  ]
}